G. Edward Griffin marshals the evidence that cancer is a deficiency disease – like scurvy or pellagra – aggravated by the lack of an essential food compound in modern man’s diet. That substance is vitamin B17. In its purified form developed for cancer therapy, it is known as Laetrile. This story is not approved by orthodox medicine. The FDA, the AMA, and The American Cancer Society have labeled it fraud and quackery. Yet the evidence is clear that here, at last, is the final answer to the cancer riddle. Why has orthodox medicine waged war against this non-drug approach? The author contends that the answer is to be found, not in science, but in politics – and is based upon the hidden economic and power agenda of those who dominate the medical establishment. With billions of dollars spent each year on research, with other billions taken in on the sale of cancer-related drugs, and with fund-raising at an all-time high, there are now more people making a living from cancer than dying from it. If the solution should be found in a simple vitamin, this gigantic industry could be wiped out over night. The result is that the politics of cancer therapy is more complicated than the science.
Can vitamin D help prevent certain cancers and other diseases such as type 1 diabetes, cardiovascular disease, and certain autoimmune and chronic diseases? To answer these questions and more, UCSD School of Medicine and Grassroots Health bring you this innovative series on vitamin D deficiency. Join nationally recognized experts as they discuss the latest research and its implications. In this program, Frank Garland, PhD, discusses vitamin D and the opportunity for prevention of diabetes. Series: Vitamin D Deficiency – Treatment and Diagnosis [2/2009] [Health and Medicine] [Professional Medical Education] [Show ID: 15771]
Millions of people take vitamins everyday convinced of their power to help hem stay healthy. However, being in the habit of taking large doses of vitamins can cause different consequences.
(5 votes, average: 4.00 out of 5)
Loading ...
Recent Comments